Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1384 of 5804
-
New drug cocktail aims to shrink Hard-to-Treat throat cancer
Disease control TerminatedThis phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to ot…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells aim to tame chronic GVHD
Disease control TerminatedThis phase I trial tests the safety, side effects, and best dose of allogeneic CD6 chimeric antigen receptor T regulatory cells (CD6-CAR Tregs) in treating patients who have chronic graft versus host disease (cGVHD) after an allogeneic hematopoietic cell transplantation (HCT). An…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New antibiotic could shield blood cancer patients from deadly infections
Disease control Recruiting nowAntibacterial prophylaxis is recommended in patients at high risk of infection, specifically patients undergoing acute leukemia induction therapy or hematopoietic stem cell transplant (HSCT) who are expected to have profound neutropenia (ANC\<100 neutrophils/milliliter) for more …
Phase: PHASE2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Poop pills may help lymphoma patients tolerate powerful cancer treatment
Disease control Recruiting nowTo find out if adding treatment with fecal microbiota transplantation (FMT) is effective at treating gut-related side effects of antibiotic treatment in participants who are receiving standard therapy with anti-CD19 chimeric antigen receptor T-cell (CAR-T cell) therapy.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can intensive day therapy help teens beat anorexia?
Disease control Recruiting nowDuring the management of chronic illnesses, the day hospital (DH) serves as a brief and effective alternative to traditional hospitalization, offering access to multidisciplinary care. Indeed, patients can benefit from a range of therapeutic tools provided by a multidisciplinary …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug aims to kickstart kidneys after transplant
Disease control OngoingThe main purpose of this study is to evaluate the safety, efficacy and tolerability of ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function. The study consists of 2 parts: part A comprises the main study period, and part B comprises the long…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug could cool menopause hot flashes without hormones
Symptom relief CompletedHot flashes are the most common reason women going through menopause seek medical attention. Hormone replacement therapy, or HRT, is most often prescribed to treat hot flashes. However, HRT can't be used by all women or for as long as may be needed. Researchers want to find othe…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New study aims to tame skin rashes in lung cancer therapy
Disease control OngoingThe purpose of this study is to evaluate whether enhanced dermatologic management can reduce incidence of grade greater than or equal to (\>=) 2 dermatologic adverse events of interest (DAEIs) when compared with standard-of-care skin management and with modified enhanced dermatol…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New scan could spot Parkinson's protein in the brain
Diagnosis Recruiting nowThe current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 11C-M503. The goal of this radiotracer is to quantify alpha-synuclein that is abnormally deposited in the brain of people with Parkinson's disease (PD). Investigators will compare …
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can a phone app curb binge drinking? new study puts digital screening to the test
Disease control CompletedThis epidemiological study (randomized clinical trial) aims to evaluate a digital Screening and Brief Intervention (e-SBI) system for reducing and preventing harmful alcohol consumption in patients treated by the Brazilian Unified Health System (SUS), compared to an in-person SBI…
Phase: NA • Sponsor: InCor Heart Institute • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Weekly shot could replace daily insulin for diabetes
Disease control CompletedThis study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine (mentioned as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema cont…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Pocket-Sized AI device could revolutionize cervical cancer screening in kenya
Diagnosis Recruiting nowThe Pocket colposcope has 510k FDA clearance and has been successfully used in \~2500 unique patients globally in Duke and non-Duke protocols to date. 1054 women who are HPV(+) and planned to undergo treatment at four Ministry of Health-supported outpatient clinics in Kisumu Coun…
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Could a Brain-Boosting pill lift depression?
Symptom relief CompletedThis study will evaluate of the efficacy and safety of SPN-820 in Adults With Major Depressive Disorder (MDD)
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Shock device may free ICU patients from ventilators faster
Symptom relief CompletedThe objective of this study is to evaluate the efficacy of the VentFree Respiratory Muscle Stimulator (VentFree) in critically ill adult patients who require invasive mechanical ventilation, when compared to sham.
Phase: NA • Sponsor: Liberate Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Stem cell jab could replace surgery for painful thumb arthritis
Disease control Recruiting nowRhizarthosis is a common disease in the population (15%). It has a major impact on the function of the hand since it compromises the pollicidigitales claws and all gripping functions with the thumb. However, no curative medical treatment exists to date. The treatment is initially…
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New app aims to curb violence and drug use in black youth
Prevention OngoingThis study will adapt and test a culturally tailored, multi-component, and trauma-focused digital intervention to reduce the risk and effects of youth violence and substance use and bridge service access gaps for young Black males (YBM) in pediatric emergency and community-based …
Phase: NA • Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple test predict ovarian cancer treatment success?
Knowledge-focused Recruiting nowThe study concerns patients with Invasive epithelial ovarian cancer, primary Fallopian tube carcinoma, ovarian-type peritoneal carcinoma, and with an indication of a first-line platinum-based chemotherapy. To determine HRD status, 2 separate tests will be performed in the study:…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
New drug combo takes on tough lung cancer
Disease control OngoingThis study is open to adults with extensive stage small cell lung cancer. The study is in people with advanced cancer that had previously received platinum-based chemotherapy and are eligible to receive a single agent chemotherapy treatment. The purpose of this study is to find …
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Radioactive lipiodol takes aim at inoperable liver tumors
Disease control TerminatedThe goal of this monocentric interventional study is to evaluate the efficacy, in terms of objective response rate, of the 188Re-SSS lipiodol SIRT in patients with non-operable HCC.
Phase: PHASE2 • Sponsor: Center Eugene Marquis • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New MRI dye aims to sharpen prostate cancer detection
Diagnosis TerminatedThe fundamental aim of this study is to show that the novel contrast agent Gadopiclenol (Elucirem), with its high relaxivity, facilitates increased contrast enhancement and improved differentiation of clinically significant prostate cancer on Prostate MRI, as categorized by the P…
Phase: PHASE4 • Sponsor: Columbia University • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC